Renal denervation and long-term results

Area of Science:

• Cardiology
• Interventional Cardiology
• Nephrology

Background:

• Arterial hypertension is a prevalent global health issue and a significant risk factor for cardiovascular events.
• Standard treatments include non-pharmacological methods, pharmacological interventions, and combination therapy to achieve blood pressure (BP) goals.
• A notable proportion of patients exhibit resistance to drug therapy or experience intolerance to antihypertensive medications.

Purpose of the Study:

• To evaluate the role of invasive treatments, specifically renal denervation, as a therapeutic option for blood pressure control in patients with resistant hypertension.
• To reassess the efficacy and safety of renal denervation in light of recent clinical trial data and long-term follow-up.

Main Methods:

• Review of recent clinical trials and long-term follow-up data on renal denervation procedures.
• Analysis of the safety and efficacy of renal denervation in achieving blood pressure targets.
• Consideration of different ablation methods beyond radiofrequency.

Main Results:

• Recent data from new trials and long-term follow-up have re-established the benefit and safety of renal denervation.
• The procedure is being relaunched into clinical practice for managing resistant hypertension.
• Initial concerns regarding negative trial results have been addressed by subsequent evidence.

Conclusions:

• Renal denervation is a valuable therapeutic option for patients with hypertension unresponsive to conventional treatments.
• Further research into various ablation techniques is necessary to optimize patient selection and procedural outcomes.
• The procedure's role in managing resistant hypertension is being redefined and expanded.